Fu Zhiping, Li Shuanglei, Xue Jingyi, Li Qiang, Jiang Tianhui, Wu Lulin, Wang Luqi, Zhang Hanying, Geng Xin, Guo Xintong, Yan Xinxin, You Hongjie, Zhang Lingxi, Zhang Yimeng, Song Tao, Wu Yongquan, Yu Xiaofeng, Hou Yunlong, Luo Dali
Department of Pharmacology, School of Basic Medical Sciences, Beijing Key Laboratory of Metabolic Disturbance Related Cardiovascular Disease, Capital Medical University, Beijing, China.
Division of Adult Cardiac Surgery, Senior Department of Cardiology, The Sixth Medical Center of PLA General Hospital, Beijing, China.
Br J Pharmacol. 2025 Jun 9. doi: 10.1111/bph.70090.
Dephosphorylation of several phosphor residues in connexin 43 (Cx43) is critically involved in ischaemia/reperfusion (I/R) arrhythmias. Here, we sought to identify constitutive Cx43-serine 282 (S282) dephosphorylation as an independent and targetable substrate to delineate reperfusion arrhythmogenesis.
Reperfusion arrhythmias were induced by rat I/R (15/45 min), identified in heterozygous knock-in mice with S282 to alanine (Cx43-S282A/+) and rescued by LB100, a specific protein phosphatase 2A (PP2A) inhibitor, via surface electrocardiogram and epicardial mapping detections. TAT-HA-L2, a mimic of Cx43-cytoplasmic-loop domain (L2), was assessed in mitigating Cx43-S282 dephosphorylation-associated arrhythmogenicity.
Upon I/R, rats exeperienced myocardium injury, ventricular tachycardia/fibrillation, increased PP2A activity and Cx43-S282 hypophosphorylation, whereas Cx43-S282A/+ mice had spontaneous ventricular arrhythmias with normal cardiac function/morphology. LB100 significantly attenuated these arrhythmias by restoring PP2A-C and Cx43-S282 phosphorylation. Slow and irregular electrical conduction, premature Ca transients and afterdepolarisations were found and normalised by LB100, or Gap19 peptide treatment (Cx43 hemichannel inhibitor), in Cx43-S282A/+ ventricles. Mechanistically, serine 282 locates within SH3-binding domain of the Cx43-carboxyl-terminus. TAT-HA-L2 bound with Cx43-S282 dephosphorylated proteins in S282A-expressed HeLa cells, as well as in S282A/+ and I/R isolated cardiomyocytes, more than in their counterpart controls. LB100 can prevent their enhanced binding and ATP release because of S282 dephosphorylation.
Cx43-S282 dephosphorylation can trigger reperfusion arrhythmias by impairing gap junction intercellular communication while favouring hemichannel permeability. An up-regulated intramolecular interaction between L2 and Cx43-carboxyl-terminus is associated with this arrhythmogenicity, providing a novel and targetable mechanism to preserve the heart from ischaemia/reperfusion arrhythmias.
连接蛋白43(Cx43)中多个磷酸化残基的去磷酸化在缺血/再灌注(I/R)心律失常中起关键作用。在此,我们试图确定组成性Cx43-丝氨酸282(S282)去磷酸化作为一个独立且可靶向的底物,以阐明再灌注心律失常的发生机制。
通过大鼠I/R(15/45分钟)诱导再灌注心律失常,在S282突变为丙氨酸的杂合敲入小鼠(Cx43-S282A/+)中识别该心律失常,并通过表面心电图和心外膜标测检测,用特异性蛋白磷酸酶2A(PP2A)抑制剂LB100挽救该心律失常。评估Cx43-细胞质环结构域(L2)的模拟物TAT-HA-L2减轻Cx43-S282去磷酸化相关的致心律失常性。
I/R后,大鼠经历心肌损伤、室性心动过速/颤动、PP2A活性增加和Cx43-S282磷酸化不足,而Cx43-S282A/+小鼠有自发性室性心律失常,心脏功能/形态正常。LB100通过恢复PP2A-C和Cx43-S282磷酸化显著减轻这些心律失常。在Cx43-S282A/+心室中发现缓慢且不规则的电传导、过早的钙瞬变和后去极化,并通过LB100或Gap19肽处理(Cx43半通道抑制剂)使其恢复正常。机制上,丝氨酸282位于Cx43羧基末端的SH3结合域内。TAT-HA-L2在表达S282A的HeLa细胞中,以及在S282A/+和I/R分离的心肌细胞中,与Cx43-SZ82去磷酸化蛋白的结合多于其相应的对照。LB100可以阻止由于S282去磷酸化导致的它们结合增强和ATP释放。
Cx43-S282去磷酸化可通过损害缝隙连接细胞间通讯同时促进半通道通透性来触发再灌注心律失常。L2与Cx43羧基末端之间分子内相互作用上调与这种致心律失常性相关,为保护心脏免受缺血/再灌注心律失常提供了一种新的可靶向机制。